Breaking News

Arzeda, Takeda Partner to Accelerate Protein Biologics Optimization

Aims to deploy AI-based protein design to optimize the properties of protein biologics in Takeda's research pipeline.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Arzeda, a Protein Design Company, has entered a collaboration with Takeda aimed at deploying AI-based protein design to optimize the properties of protein biologics.   Takeda will leverage Arzeda’s Intelligent Protein Design Technology, which has the potential to accelerate the optimization of proteins that can be incorporated into therapeutic products. Applying the latest advances in digital biology, using computational design and machine learning algorithms, the collaboration aims to h...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters